One of the most novel and promising strategies in medical research and the fight against cancer is the combination of DNA and messenger RNA vaccines. This new book explores the therapeutic uses, the biological processes, and the difficulties related to this novel strategy for cancer immunotherapy. Offering a unique perspective on different facets of DNA- and mRNA-based cancer vaccines, the authors present a thorough overview of the constantly changing field of cancer immunotherapy, from explaining the unique aspects of tumor angiogenesis and the role that non-coding RNAs play in treatment resistance, to investigating the most recent developments in gene therapy and splicing control. The volume also looks at this fascinating field's future potential, giving cancer patients hope for less intrusive and more effective therapies.